A Prospective Study of Treatment Patterns and 1-Year Outcome of Asian Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

(2013) Frank G Holz et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy

(2013) Chui Ming Gemmy Cheung et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

(2013) Usha Chakravarthy et al.   LANCET

POLYPOIDAL CHOROIDAL VASCULOPATHY

(2013) Adrian H.C. Koh et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany

(2012) Robert P. Finger et al.   ACTA OPHTHALMOLOGICA

Treatment Patterns for Neovascular Age-Related Macular Degeneration: Analysis of 284 380 Medicare Beneficiaries

(2012) Lesley H. Curtis et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration

(2012) Sreekumari Pushpoth et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Age-related macular degeneration

(2012) Laurence S Lim et al.   LANCET

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

(2012) Daniel F. Martin et al.   OPHTHALMOLOGY

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

(2012) Jeffrey S. Heier et al.   OPHTHALMOLOGY

EVEREST STUDY

(2012) Adrian Koh et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Ranibizumab treatment administered as needed for occult and minimally classic neovascular membranes in age-related macular degeneration

(2011) Seungbum Kang et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study

(2011) Lars Hjelmqvist et al.   Journal of Ophthalmology

Impact of early and late age-related macular degeneration on vision-specific functioning

(2010) E. L. Lamoureux et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

The Prevalence of Age-Related Macular Degeneration in Asians

(2010) Ryo Kawasaki et al.   OPHTHALMOLOGY

Results of One-Year's Treatment with Ranibizumab for Exudative Age-related Macular Degeneration in a Clinical Setting

(2009) Salomon Y. Cohen et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease?

(2009) Augustinus Laude et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Two-Year Results of Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

(2008) Yumiko Kurashige et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy

(2008) T Y Y Lai et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: A One-year Prospective Study

(2007) Ziad F. Bashshur et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients

(2007) Fumi Gomi et al.   OPHTHALMOLOGY